Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy.

Rossi F, Bellini G, Luongo L, Torella M, Mancusi S, De Petrocellis L, Petrosino S, Siniscalco D, Orlando P, Scafuro M, Colacurci N, Perrotta S, Nobili B, Di Marzo V, Maione S; Endocannabinoid Research Group (ERG), Italy.

Bone. 2011 May 1;48(5):997-1007. doi: 10.1016/j.bone.2011.01.001. Epub 2011 Jan 13.

PMID:
21237298
2.

The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption.

Rossi F, Siniscalco D, Luongo L, De Petrocellis L, Bellini G, Petrosino S, Torella M, Santoro C, Nobili B, Perrotta S, Di Marzo V, Maione S.

Bone. 2009 Mar;44(3):476-84. doi: 10.1016/j.bone.2008.10.056. Epub 2008 Nov 14.

PMID:
19059369
3.

Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Rossi F, Perrotta S, Bellini G, Luongo L, Tortora C, Siniscalco D, Francese M, Torella M, Nobili B, Di Marzo V, Maione S.

Haematologica. 2014 Dec;99(12):1876-84. doi: 10.3324/haematol.2014.104463. Epub 2014 Sep 12.

4.

CB(2) and TRPV(1) receptors oppositely modulate in vitro human osteoblast activity.

Rossi F, Bellini G, Tortora C, Bernardo ME, Luongo L, Conforti A, Starc N, Manzo I, Nobili B, Locatelli F, Maione S.

Pharmacol Res. 2015 Sep;99:194-201. doi: 10.1016/j.phrs.2015.06.010. Epub 2015 Jun 25.

PMID:
26117426
5.

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):87-92.

PMID:
15548432
6.

The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression.

Rossi F, Bellini G, Luongo L, Mancusi S, Torella M, Tortora C, Manzo I, Guida F, Nobili B, de Novellis V, Maione S.

Pharmacol Res. 2013 Feb;68(1):7-15. doi: 10.1016/j.phrs.2012.10.017. Epub 2012 Nov 6.

PMID:
23142558
7.

[The endocannabinoid system and bone].

Pura M, Vaňuga P.

Vnitr Lek. Fall 2016;62(9 Suppl 3):99-102. Czech.

PMID:
27734700
8.

Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro.

Whyte LS, Ford L, Ridge SA, Cameron GA, Rogers MJ, Ross RA.

Br J Pharmacol. 2012 Apr;165(8):2584-97. doi: 10.1111/j.1476-5381.2011.01519.x.

9.

The genetic ablation or pharmacological inhibition of TRPV1 signalling is beneficial for the restoration of quiescent osteoclast activity in ovariectomized mice.

Rossi F, Bellini G, Torella M, Tortora C, Manzo I, Giordano C, Guida F, Luongo L, Papale F, Rosso F, Nobili B, Maione S.

Br J Pharmacol. 2014 May;171(10):2621-30. doi: 10.1111/bph.12542.

10.

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

Spoto B, Fezza F, Parlongo G, Battista N, Sgro' E, Gasperi V, Zoccali C, Maccarrone M.

Biochimie. 2006 Dec;88(12):1889-97. Epub 2006 Aug 22.

PMID:
16949718
11.

β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.

Benito C, Tolón RM, Castillo AI, Ruiz-Valdepeñas L, Martínez-Orgado JA, Fernández-Sánchez FJ, Vázquez C, Cravatt BF, Romero J.

Br J Pharmacol. 2012 Jun;166(4):1474-89. doi: 10.1111/j.1476-5381.2012.01889.x.

12.

Characterization of the endocannabinoid system in human spermatozoa and involvement of transient receptor potential vanilloid 1 receptor in their fertilizing ability.

Francavilla F, Battista N, Barbonetti A, Vassallo MR, Rapino C, Antonangelo C, Pasquariello N, Catanzaro G, Barboni B, Maccarrone M.

Endocrinology. 2009 Oct;150(10):4692-700. doi: 10.1210/en.2009-0057. Epub 2009 Jul 16.

PMID:
19608651
13.

Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction.

Maccarrone M, Barboni B, Paradisi A, Bernabò N, Gasperi V, Pistilli MG, Fezza F, Lucidi P, Mattioli M.

J Cell Sci. 2005 Oct 1;118(Pt 19):4393-404. Epub 2005 Sep 6.

14.

The endocannabinoid system and pivotal role of the CB2 receptor in mouse spermatogenesis.

Grimaldi P, Orlando P, Di Siena S, Lolicato F, Petrosino S, Bisogno T, Geremia R, De Petrocellis L, Di Marzo V.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11131-6. doi: 10.1073/pnas.0812789106. Epub 2009 Jun 18.

15.

First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands.

Appendino G, Cascio MG, Bacchiega S, Moriello AS, Minassi A, Thomas A, Ross R, Pertwee R, De Petrocellis L, Di Marzo V.

FEBS Lett. 2006 Jan 23;580(2):568-74. Epub 2005 Dec 29.

16.

The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

Steiner AA, Molchanova AY, Dogan MD, Patel S, Pétervári E, Balaskó M, Wanner SP, Eales J, Oliveira DL, Gavva NR, Almeida MC, Székely M, Romanovsky AA.

J Physiol. 2011 May 1;589(Pt 9):2415-31. doi: 10.1113/jphysiol.2010.202465. Epub 2011 Mar 14.

17.

TRPV1, TRPA1, and CB1 in the isolated vagus nerve--axonal chemosensitivity and control of neuropeptide release.

Weller K, Reeh PW, Sauer SK.

Neuropeptides. 2011 Dec;45(6):391-400. doi: 10.1016/j.npep.2011.07.011. Epub 2011 Aug 24.

PMID:
21868092
18.

Distribution and function of the endocannabinoid system in the rat and human bladder.

Bakali E, Elliott RA, Taylor AH, Willets J, Konje JC, Tincello DG.

Int Urogynecol J. 2013 May;24(5):855-63. doi: 10.1007/s00192-012-1954-1. Epub 2012 Oct 19.

PMID:
23081739
19.

The endocannabinoid system is modulated in response to spinal cord injury in rats.

Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, Bisogno T, Watanabe M, Guaza C, Di Marzo V, Molina-Holgado E.

Neurobiol Dis. 2009 Jan;33(1):57-71. doi: 10.1016/j.nbd.2008.09.015. Epub 2008 Sep 30.

PMID:
18930143
20.

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.

Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J.

Neurobiol Dis. 2005 Nov;20(2):207-17.

PMID:
16242629

Supplemental Content

Support Center